Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Microprofit Biotech develops and commercializes in vitro diagnostic kits based on immunofluorescence quantitative assays. Their fluorecare platform enables rapid point-of-care testing across more than 60 parameters in oncology, endocrinology/hormones, cardiology, infectious diseases including reproductive tract pathogens and diabetes. Their genital tract pathogen detection kits have received CFDA approval and widespread use in top Chinese hospitals specializing in women’s health. No clinical trial data as they do not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Microcore Biotechnology.